of the inducer in colonies. To overcome these limitations, we synthesized a 1 4 4 set of five constitutive promoters (00, JJ, K, E, and W) based on (21). In repeat of the tetranucleotide (GACT) n=44 . To increase the range of expression rate (12, 22) . Interestingly, the transposition rate peaks with the weakest 2 1 6 promoters in the single copy vector indicating that the transposition rate is 2 1 7 extremely sensitive to overproduction inhibition (OPI) resulting from a slight 2 1 8 increase in the transposase concentration. However, for the expression 2 1 9
vectors with a similar average promoter strength but a transposition rate 2 2 0 below the highest one we cannot determine whether their suboptimal 2 2 1 transposition rate is due to an insufficient amount of Hsmar1 transposase in 2 2 2 the cell or OPI. Importantly, the transposition assay also provides a more precise approach to 2 2 4 investigate weak promoter strength than flow cytometry with EGFP. Indeed, 2 2 5 out of the 18 expression vectors having a relative promoter strength around 2 2 6 4% of Ip6+, the transposition assay shows a 10-fold change in transposition 2 2 7 rate within this set of vectors ( Figure 2C ). Bounding covalently two Hsmar1 monomers in a dimer affects the 2 3 0 transposition rate 2 3 1
We recently published a new Hsmar1 construct where two monomers are 2 3 2 covalently bound by a linker region ( Figure 3A ) (23). We use advantage of our monomers close to each other, and also because the covalent dimer requires 2 3 8 a single translation event whereas the monomer requires two. We cloned the 2 3 9 monomeric and dimeric construct in a set of expression vectors spanning from 2 4 0 very low to high expression and performed a papillation assay.
4 1
Representative colony of the papillation assay of each expression vectors is 2 4 2 shown in Figure 3B and their respective whole plate pictures are shown in Hsmar1 monomer, the covalent dimer transposition rate peaks at a different 2 4 7 set of expression vectors, Bp2-and Bp3-for the covalent dimer and Ip2-and as the monomer, which is also supported by the inverse relationship between 2 5 5 the average promoter strength and the transposition rate for both the 2 5 6 monomer and the covalent dimer ( Figure 3D ). Hsmar1 transposition ( Figure 4A ). Most of the mutations present in the human 2 6 8 SETMAR occurred outside the DNA binding domain and happened at the at the same time as the domestication of the Hsmar1 transposase. The mutagenic nature of transposable elements make them useful in 2 8 4 screening for essential genes. However, OPI limits the transposition rate 2 8 5
when the transposase concentration is too high (12). One way to overcome 2 8 6
OPI is to decrease the stability of the Hsmar1 dimer to shift the monomer-2 8 7 dimer equilibrium to the inactive monomeric form. We decided to take 2 8 8 advantage of our approach to investigate two Hsmar1 transposases mutated 2 8 9
in the dimer interface, one known mutant, F132A (F460 in SETMAR (27)) and 2 9 0 a novel one R141L (9). We used three vectors expressing Hsmar1 at a low 2 9 1 (Bp1+), optimal (Ip1+) and high (Ip6+) level. Representative colony of the 2 9 2 papillation assay of each expression vectors is shown in Figure 4C and their low and optimal levels of expression when compared to WT. A higher 2 9 7 transposition rate is also observed at high expression level for both mutants, with R141L showing a stronger resistance to OPI than F132A. To confirm the 2 9 9 papillation assay, the mutants' transposition rate was also determined using 3 0 0 the mating-out assay, a more quantitative assay measuring the transposition 3 0 1 rate through the movement of the transposon reporter from its chromosomal 3 0 2 location into a conjugative plasmid ( are the average of three independent experiments ± standard error of the mean. We present here an improvement of the papillation assay using a set of 3 1 6
constitutive promoters cloned into a single-or five-copies vector in absence or pTac. This is illustrated in Figure 2C where we observe a large variation in the 3 2 0 number of papillae per colony across expression vectors producing EGFP We recently published a covalently bound Hsmar1 construct, where a single 3 2 6
transcription and translation event is sufficient to synthesize an active Hsmar1 this idea, we can hypothesize that Bp2-and Bp3-, which provides the highest transposition rates for the covalent dimer, corresponds to weaker promoters 3 3 7
than Ip2-and Ip1+, which provides the highest transposition rates for the 3 3 8
monomeric Hsmar1 but lower transposition rate for the covalent dimer. Thus, 3 3 9
Bp2-and Bp3-are likely to express on average less than two proteins per cell,
which is not sufficient to optimally promote transposition for the Hsmar1 (Tellier, M. and Chalmers, R., manuscript under review). It was shown that the ( Figure 4A and B) . Out of the 23 mutations, only one was found to increase 3 5 7 the transposition rate in the papillation assay, V201L, whereas 12 mutations 3 5 8
were deleterious for the transposition rate with three of them abolishing it assay. It will be interesting to determine whether this effect is mediated Transposases have become an important and versatile biotechnological tool its wild-type counterpart as for transposon mutagenesis for example. One of 3 7 2 the major mechanism limiting the transposition rate of mariner transposases is transposon (11, 12) . We previously show that mutating the conserved 3 7 5
WVPHEL motif, which is part of the Hsmar1 transposase dimer interface, mutation of the residues F132 and R141, which are located in the subunit R141L mutant being OPI-resistant ( Figure 4C and Table 1 ). The hyperactivity transposition. This type of mutant is more likely to be found hyperactive only for a smaller fraction of the genome, will increase the time necessary for a 3 9 1 transposase to find a transposon end. Therefore, transposases with a 3 9 2 weakened dimer interface are more likely to revert to an inactive monomeric 3 9 3 state resulting in hypoactive mutants. An unexpected outcome of our range of expression vectors is the realization 3 9 6
that the transposition rate could be used as a better approach than EGFP 3 9 7
fluorescence to compare the strength of a series of weak promoters. This is 3 9 8 illustrated in Figure 1B where 18 of our expression vectors have a relative 3 9 9
promoter strength comprised between 3 and 4% of Ip6+, our strongest vector. However, in Figure 2C , we observe a 10-fold difference in the transposition 4 0 1 rate between these 18 expression vectors. It is interesting to note that the rate in E. coli. We previously shown that OPI starts to occur when two 4 0 7 transposase dimers are present in a single cell (12). This therefore shows that shown in Figure 2C . We present in this study an improvement of the papillation assay using a set promoters based on pItetO ranging from strong down to very weak (21). We 4 4 7 select the promoters 00, jj, K, E, and W (equivalent to p2, p3, p4, p5, and p6 4 4 8 in this study) and generate p1, a featureless tract of 44 GACT repeats which 4 4 9
we represent an ideal promoter-less region (Table 1) . Each promoter 4 5 0 sequence is preceded by three terminator sequences and followed by a sequence ( Figure 1A) . Cells containing a derivative of pMAL-c2x were grown in LB supplemented 1996;13(4):549-55. Figure 4 
